Mediplus was established in the United Kingdom in 1986. The Company's focus is the research, development, manufacture and marketing of innovative medical devices that meet the needs of patients and clinicians worldwide. The Mediplus philosophy is to provide high quality products at fair prices supported by excellence in customer service. The Company sells direct to end-users in the United Kingdom and to more than forty countries internationally through a network of carefully selected distributors. The first Mediplus range of products, developed for the urodynamic market, highlights this philosophy. Mediplus was the first company to develop colour-coded lines, incorporate extension sets and feature an offset lumen to allow greater filling rates. The Mediplus urodynamic range is used throughout the world by clinicians who care about patient comfort. Since 1986 Mediplus has used its expertise in manufacturing to develop and launch products for the Urology, Urogynaecology, Gynaecology, Gastroenterology, Anaesthetics, and General Surgery sectors. Mediplus is a medical devices innovation company. Since 1986 company successes include: - Launch of the world's first non-invasive pressure flow study system - the CT3000. Designed to accurately predict Bladder Outlet Obstruction, it provides comparable results to traditional invasive urodynamics with a high level of patient comfort and the capability to test more patients per day.
- Development and launch of Siamese tubing and colour coding in the anaesthetic range to prevent entanglement and deliver increased patient safety through reduction in medication errors.
- Development of the Mediplus Suprapubic Catheter system; an easier and safer method of introducing a Foley catheter suprapubically. This product does not require general anaesthetic and is therefore in demand from hospitals who wish to deliver high quality care at lower cost.
- Introduction of a location device for non-palpable breast lesions that enables a surgeon to operate in a cosmetically effective manner.
| 
